`
`CURRICULUM VITAE
`
`1
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`January 10, 2014
`
`
`
`Richard Kenneth Parrish II
`
`(305) 666-1722
`
`(305) 326-6389
`
` (305) 326-6478
`
`7690 Ponce de Leon Road
`Miami, Florida 33143
`900 N.W. 17th Street
`Miami, Florida 33136
`rparrish@ med.miami.edu
`Professor
`Ophthalmology
`None
`USA
`N/A
`
` - INTERNET:
`
`
`
`CURRENT RANK:
`
`
`
`
`PRIMARY DEPARTMENT:
`
`
`SECONDARY OR JOINT APPOINTMENTS:
`CITIZENSHIP:
`
`
`
`
`VISA TYPE:
`
`
`
`
`
`
`DATE:
`
`
`
`
`UNIVERSITY OF MIAMI
`
`
`
`1.
`
`PERSONAL
`
`2.
`3.
`4.
`
`NAME:
`
`PHONE - HOME:
`PHONE - OFFICE:
` - FAX:
`ADDRESS - HOME:
`
`5.
`
`
`
`
`
`
`
`
`
` - OFFICE:
`
`6.
`7.
`8.
`9.
`10.
`
`HIGHER EDUCATION
`
`11.
`
`
`INSTITUTION:
`
`August, 1969 – May,1972
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Indiana University, Bloomington, Indiana Bachelor of Arts in
`Biological Sciences - High Distinction
`
`Indiana University School of Medicine,
`Indianapolis, Indiana, M.D., April 1976
`
`University of Alabama, Birmingham, Alabama (Internship in
`Medicine)
`
`Wills Eye Hospital, Philadelphia, Pennsylvania (Resident)
`
`Wills Eye Hospital, Philadelphia, Pennsylvania (Chief Resident)
`
`Bascom Palmer Eye Institute/Anne Bates Leach Eye Hospital
`University of Miami School of Medicine, Miami, Florida
`(Clinical Fellow, Glaucoma)
`
`Bascom Palmer Eye Institute/ Anne Bates Leach Eye Hospital
`University of Miami School of Medicine, Miami, Florida
`(Research Fellow, Glaucoma)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`12.
`
`13.
`
`
`
`August, 1972 – April, 1976
`
`
`
`
`
`June 24, 1976 - June 23, 1977
`
`
`
`
`
`July 5, 1977 - June 30, 1980
`
`July 1, 1979 - June 30, 1980
`
`July 1, 1980 - June 30, 1981
`
`
`
`July 1, 1981 - June 30, 1982
`
`
`
`NON-INSTITUTIONAL:
`
`None
`
`CERTIFICATION, LICENSURE:
`
`
`
`ALCON 2010
`Apotex Corp. v. Alcon Research, Ltd.
`Case IPR2013-00428
`
`

`

`
`
`2
`
`Indiana License # 01027135, Renewal #H460623
`Florida License #ME40377, 2002-
`American Board of Ophthalmology, 1981
`Pennsylvania #MD-020124-E, 1977-1980
`New Jersey #34604, 1978-1980
`
`Assistant Professor, University of Miami School of Medicine, Department of
`Ophthalmology, Miami, Florida
`
`
`EXPERIENCE
`
`14.
`
`
`ACADEMIC:
`
`1982- 1989
`
`
`
`
`
`
`
`
`
`15.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1982- 1983
`
`
`
`1989 - 1994
`
`Staff Surgeon, Section of Ophthalmology, Department of Surgery, Veterans Medical
`Center, Miami, Florida
`
`Associate Professor, University of Miami School of Medicine, Department of
`Ophthalmology, Miami, Florida
`
`1994 -
`
`Professor, University of Miami School of Medicine, Department of Ophthalmology,
`Miami, Florida
`
`NON-ACADEMIC:
`
`1982
`
`1983
`
`1984
`
`
`
`
`
`
`
`Faculty Resident Supervisor - July – September, University of Miami School of
`Medicine, Department of Ophthalmology, Miami, Florida
`
`Coordinator - Ophthalmology Section, Introduction to Physical Diagnosis, Sophomore
`Class, University of Miami School of Medicine, Miami, Florida
`
`Coordinator - Ophthalmology Section, Introduction to Physical Diagnosis, M.D.-Ph.D.
`Class, University of Miami School of Medicine, Miami, Florida
`
`1993 – 1999 Director, Residency Training Program, University of Miami School of Medicine,
`Department of Ophthalmology, Miami, Florida
`
`1996 – 1999 Chairman, Department of Ophthalmology, University of Miami School of Medicine,
`Miami, Florida
`
`2000 -
`
`
`2000 -
`
`2004-
`
`Associate Dean for Graduate Medical Education, University of Miami School of
`Medicine, Miami, Florida
`
`Chairman, Graduate Medical Education Committee, Jackson Health System, Jackson
`Memorial Hospital, Miami, Florida
`
`Designated Institutional Official, Jackson Health System, Jackson Memorial Hospital,
`Miami, Florida
`
`
`
`16. MILITARY: None.
`
`
`
`
`
`

`

`
`
`3
`
`PUBLICATIONS
`
`17. BOOKS, BOOK CHAPTERS:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Gressel MG, Parrish RK II, Heuer DK: Surgical management of problem cases. In: Glaucoma,
`edited by JA MacAllister, R Wilson. London: Butterworths, 1986; pp. 255-269.
`
`Loertscher H, Parel J-M, Parrish RK II, Mandelbaum S: Laser trephination of the cornea. In: Laser
`Technology in Ophthalmology, edited by J Marshall. Amsterdam: Kugler & Ghedini, 1988; pp
`195-204.
`
`Loertscher H, Mandelbaum S, Parrish RK II: Effect of selected beam parameters on corneal
`incisions produced with a hydrogen fluoride laser. In: Laser Technology in Ophthalmology, edited
`by J Marshall. Amsterdam: Kugler & Ghedini, 1988; pp. 275-281.
`
`Parrish RK II, Folberg R: Wound healing and antifibrosis therapy in glaucoma filtering procedures.
`In: Perspectives in Glaucoma; Transactions of the First Scientific Meeting of the American
`Glaucoma Society, edited by MB Shields, IP Pollack, AE Kolker. Thorofare NJ: Slack, 1988; pp.
`175-181.
`
`Parrish RK II: Filtering procedures in patients predisposed to failure. In: Current Therapy in
`Ophthalmic Surgery, edited by GL Spaeth, LJ Katz, KW Parker. Toronto, Philadelphia: Decker,
`1989; pp. 182-186.
`
`Parrish RK II, Folberg R: Wound healing in glaucoma surgery. In: The Glaucomas.
`Edited by R Ritch, MB Shields, T Krupin, St. Louis: C.V. Mosby, 1989; pp. 633-643.
`
`Parrish RK II: The role of antimetabolites in filtering surgery. In: New Frontiers in
`Ophthalmology; Proceedings of the XXVI International Congress of Ophthalmology, Singapore,
`1990, edited by CY Khoo, BC Ang, WM Cheah, PTK Chew, ASM Lim. Amsterdam: Elsevier
`Science Publishers, 1991; pp. 15-17.
`
`Parrish RK II: Rationale for management of refractory glaucoma (antimetabolites,
`cyclodestruction, drainage implants). In: Color Atlas of Ophthalmic Surgery, edited by DS
`Minckler, EM Van Buskirk. Philadelphia: Lippincott, 1992; pp.139-146.
`
`Parrish RK II: Perioperative Behandlung in der Glaukomchirurgie In: Das Glaukom, Aspekte aus
`der Forschung fur die Praxis, edited by LE Pillunat, R Stodtmeister. Berlin: Springer-Verlag, 1993;
`pp.255-260.
`
`Hodapp E, Parrish RK II, Anderson DR: Clinical Decisions in Glaucoma. St. Louis: Mosby -Year
`Book, 1993.
`
`Davis PA, Parrish RK II: Antiproliferative agents. In: Principles and Practice of Ophthalmology,
`edited by DM Albert, FA Jakobiec. Philadelphia: WB Saunders, 1994; pp. 1085-1092.
`
`
`
`
`

`

`
`
`
`
`
`4
`
`
`Wright WW, Parrish RK II: Antimetabolites in filtering surgery. In: Textbook of Ophthalmology.
`Volume 7: Glaucoma, edited by PL Kaufman, TW Mittag. St. Louis: Mosby, 1994; section VI, pp.
`952-961.
`
`Parrish RK II: The use of antifibrotic agents in refractory glaucoma. In: The Refractory
`Glaucomas, edited by F El Sayyad, et al. New York: Igaku-Shoin, 1995; pp. 180-199.
`
`Grajewski AL, Parrish RK II: Acute angle-closure glaucoma. In: The Clinical Practice of
`Emergency Medicine, edited by AL Harwood-Nuss. Philadelphia: Lippincott-Raven, 1996; pp. 52-
`61.
`
`Parrish RK II, Folberg R: Wound healing in glaucoma surgery. In: The Glaucomas, 2nd ed., edited
`by R Ritch, MB Shields, T Krupin. St. Louis: Mosby; pp. 1633-1651.
`
`Parrish RK II, editor: The University of Miami Bascom Palmer Eye Institute’s Atlas of
`Ophthalmology. Philadelphia: Current Medicine, 1999.
`
`Parrish RK II: Preface. In: The University of Miami Bascom Palmer Eye Institute’s Atlas of
`Ophthalmology. Philadelphia: Current Medicine, 1999; p. xviii.
`
`Parrish RK II: Complications of glaucoma filtering surgery. In: The University of Miami Bascom
`Palmer Eye Institute’s Atlas of Ophthalmology, edited by RK Parrish II. Philadelphia: Current
`Medicine, 1999; pp. 224-231.
`
`Lerner SF, Parrish RK II: Cirugia de Glaucoma Barcelona: Edika Med, 2000.
`
`Davis-Lemessy PA, Parrish RK II: Antimetabolites for trabeculectomy: 5-fluorouracil and
`mitomycin. In: Principles and Practice of Ophthalmology, 2nd ed., edited by Albert DM, Jakobiec
`FA. Philadelphia: W.B. Saunders, 2000; pp 354-363
`
`Parrish RK II, Gedde SJ: Guarded filtration procedure with 5-fluorouracil. In: Ophthalmic Surgery;
`Principles and Practice, 3d ed., edited by Spaeth GL, Philadelphia, WB Saunders, 2003, pp. 273-
`279.
`
`Lerner SF, Parrish RK II: Glaucoma Surgery. Philadelphia: Lippincott Williams & Wilkins, 2003.
`
`Schwartz K, Parrish RK II: When should we treat ocular hypertensives? In: Susanna R, ed:
`Important Questions About Glaucoma, São Paulo, Brazil, Editor Cultura Medica, Rio de Janeiro,
`Brazil
`
`Fechter HP, Parrish RK II: Preventing and treating complications of Baerveldt glaucoma implant
`surgery. In: Ophthalmology Clinics of North America, edited by Nguyen Q, Vol 44, No 2, Spring
`2004.
`
`Khator P, Parrish RK II: Choroidal effusions. Chapter. Surgical Techniques in Ophthalmology:
`Glaucoma Surgery. Edited by Chen T, Elsevier Science, 2008.
`
`Ansari H, Parrish RK II. Which patients with ocular hypertensives should I treat? Chapter 17. In
`Curbside Consultation in Glaucoma. Edited by Heuer DK, Gedde S, Lewis R. Slack, 2008.
`
`
`
`
`

`

`
` Donaldson K, Parrish RK II. Nanophthalmos, Relative Anterior Microphthalmos, and Axial
`Hyperopia, Chapter 34 in Cataract Surgery, 3rd Edition. Edited by Steinert R, Elsevier Limited, UK,
`2009.
`
`Neelakantan A, Parrish RK II, Indications. Section 16, Chapter 16 Modulation of wound healing. In
`Glaucoma Volume 2, Surgical Management. Edited by Shaarway TM, Sherwood MB, Hitchings
`RA, Crowston JG. Saunders Elsevier Limited, 2009
`
`
`18. JURIED OR REFEREED JOURNAL ARTICLES:
`
`
`5
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Martin WG, Brown GC, Parrish RK II, Naidoff MA, Benson WE: Ocular toxoplasmosis and visual
`field defects. Am J Ophthalmol 90:25-29, 1980.
`
`Magargal LE, Brown GC, Augsburger JJ, Parrish RK II: Neovascular glaucoma following branch
`vein occlusion. Glaucoma 3:333-335, 1981.
`
`Magargal LE, Brown GC, Augsburger JJ, Parrish RK II: Neovascular glaucoma following central
`retinal vein obstruction. Ophthalmology 88:1095-1101, 1981.
`
`Parrish RK II, Bernardino V: Iridectomy in the surgical management of eight-ball hyphema. Arch
`Ophthalmol 100:435-437, 1982.
`
`Gass JDM, Parrish RK II: Outer retinal ischemic infarction-- A newly recognized complication of
`cataract surgery and closed vitrectomy: Part I. A case report. Ophthalmology 89:1467-1471,
`1982.
`
`Parrish RK II, Gass JDM, Anderson DR: Outer retinal ischemic infarction: A newly recognized
`complication of cataract surgery and closed vitrectomy: Part II. An animal model. Ophthalmology
`89:1472-1477, 1982.
`
`Saclarides EE, Parrish RK II, Saclarides TJ: Fundamentals in Focus - Ocular Emergencies. J
`Ophthalmic Nurs Technol 1:43-49, 1982.
`
`Nowinski T, Bernardino V, Naidoff M, Parrish RK II: Ocular involvement in lupus erythematosus
`profundus (panniculitis). Ophthalmology 89:1149-1154, 1982.
`
`Weiss JS, Parrish RK II, Anderson DR: Surgical therapy of traumatic hyphema. Ophthalmic Surg
`14:343-345, 1983.
`
`Parrish RK II, Herschler J: Eyes with end-stage neovascular glaucoma: Natural history following
`successful modified filtering operation. Arch Ophthalmol 101:745-746, 1983.
`
`Parrish RK II, Spaeth GL, Poryzees EM, Hargens CW: Evaluation of local anesthesia agents using
`a new force-sensitive lid speculum. Ophthalmic Surg 14:575-578, 1983.
`
`Parrish RK II, Schiffman J, Anderson DR: Static and kinetic visual field testing; reproducibility in
`normal volunteers. Arch Ophthalmol 102:1497-1502, 1984.
`
`Parrish RK II, Heuer DL. Gressel MG: Toxic effect of fluorouracil on the rabbit retina. Am J
`Ophthalmol 97: 533-534, 1984.
`
`
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`6
`
`Gressel MG, Parrish RK II, Folberg R: 5-Fluorouracil and glaucoma filtering surgery. I. An animal
`model. Ophthalmology 91:378-383, 1984.
`
`Heuer DK, Parrish RK II, Gressel MG, Hodapp E, Palmberg PF, Anderson DR: 5-fluorouracil and
`glaucoma filtering surgery II. A Pilot Study. Ophthalmology 91:384-394,1984.
`
`Heuer DK, Gressel MG, Parrish RK II, Anderson DR, Hodapp EA, Palmberg PF: Trabeculectomy
`in aphakic eyes. Ophthalmology 91:1045-1051, 1984.
`
`Gressel MG, Heuer DK, Parrish RK II: Trabeculectomy in young patients. Ophthalmology
`91:1242-1246, 1984.
`
`Gressel MG, Parrish RK II, Heuer DK: Delayed nonexpulsive suprachoroidal hemorrhage. Arch
`Ophthalmol 102:1757-1760, 1984.
`
`Slomovic AR, Parrish RK II: Neodymium:YAG laser posterior capsulotomy: visual acuity
`outcome and intraocular pressure elevation. Can J Ophthalmol 20:101-104, 1985.
`
`Slomovic AR, Parrish RK II: Acute elevations of intraocular pressure following Nd:YAG laser
`posterior capsulotomy. Ophthalmology 92:973-976, 1985.
`
`Slomovic AR, Parrish RK II, Sherman R: Corneal endothelial trauma after Descemet's
`membranotomy with the neodymium-YAG laser. Am J Ophthalmol 99:484-485, 1985.
`
`Fantes FE, Heuer DK, Parrish RK II, Sossi N, Gressel MG: Topical Fluorouracil.
`pharmacokinetics in normal rabbit eyes. Arch Ophthalmol 103:953-955, 1985.
`
`Shapiro MS, Thoft RA, Friend J, Parrish RK II, Gressel MG: 5-Fluorouracil toxicity to the ocular
`surface epithelium. Invest Ophthalmol Vis Sci 26:580-583, 1985.
`
`Mallick KS, Hajek AS, Parrish RK II: Fluorouracil (5-FU) and cytarabine (Ara-C) inhibition of
`corneal epithelial cell and conjunctival fibroblast proliferation. Arch Ophthalmol 103:1398-1402,
`1985.
`
`Knighton RW, Slomovic AR, Parrish RK II: Glare measurements before and after
`Neodymium:YAG laser posterior capsulotomy. Am J Ophthalmol 100:708-713,1985.
`
`Desjardins D, Parrish RK II: Inversion of anterior chamber pigment a possible prognostic sign in
`narrow angles. Am J Ophthalmol 100:480-481,1985.
`
`Heuer DK, Gressel MG, Parrish RK II, Folberg R, Dilberger JE, Altman NH: Topical fluorouracil.
`II. Postoperative administration in an animal model of glaucoma filtering surgery. Arch
`Ophthalmol 101:132-136,1986.
`
`Heuer DL. Parrish RK II, Gressel MG, Hodapp E, Desjardins DC, Skuta GL, Palmberg PF,
`Nevarez JA, Rockwood EJ: 5-fluorouracil and glaucoma filtering surgery. III. Intermediate follow-
`up of a pilot study. Ophthalmology 93: 1537-1546,1986.
`
`
`
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Hajek AS, Parrish RK II, Mallick KS, Gressel M: In vitro inhibition of ocular cell proliferation
`with ara-C: blockage of the antiproliferative effect with 2’-deoxycytidine. Invest Ophthalmol Vis
`Sci 27: 1010-1012, 1986.
`
`7
`
`Klein TB, Slomovic AR, Parrish RK II: Visual acuity prediction before Nd:YAG laser posterior
`capsulotomy. Ophthalmology 93:808-810,1986.
`
`Thomas MA, Parrish RK II, Feuer WE: Rebleeding after traumatic hyphema. Arch Ophthalmol
`104: 206-210,1986.
`
`Slomovic AR, Parrish RK II, Forster RK, Cubillas A: Neodymium-YAG laser posterior
`capsulotomy; central corneal endothelial density. Arch Ophthalmol 104: 536-538,1986.
`
`Desjardins DC, Parrish RK II, Folberg R, Nevarez J, Heuer D, Gressel MG: Wound healing after
`filtering surgery in owl monkeys. Arch Ophthalmol 104:1835-1839, 1986.
`
`Loeertscher H, Mandelbaum S, Parrish RK II, Parel JM: Preliminary report on corneal incisions
`created by a hydrogen fluoride laser. Am J Ophthalmol 102: 217-221, 1986.
`
`Rivera AH, Hajek AS, Fantes F, Mallick KS, Parrish RK II: Trifluorothymidine and 5-fluorouracil:
`antiproliferative activity in tissue culture. Can J Ophthalmol 22:13-16, 1987.
`
`Rockwood EJ, Parrish RK II, Heuer DK, Skuta GL, Hodapp E, Palmberg PF, Gressel MG, Feuer
`W: Glaucoma filtering surgery with 5-fluorouracil. Ophthalmology 94: 1071-1078, 1987.
`
`Skuta GL, Parrish RK II: Wound healing in glaucoma filtering surgery. Surv Ophthalmol 32: 149-
`170, 1987.
`
`Thompson K, Trentacoste J, Parrish RK II, Berman MR: Corneal photoablation by far ultraviolet
`lasers. Arch Ophthalmol 105:312-313, 1987.
`
`Trentacoste J, Thompson K, Parrish RK II, Hajek A, Berman MR, Ganjei P: Mutagenic potential
`of a 193-nm excimer laser on fibroblasts in tissue culture. Ophthalmology 94:125-129, 1987.
`
`Nevárez JA, Parrish RK II, Heuer DK, Hajek AS, Houdek PV, Mallick KS. The effect of beta
`irradiation on monkey Tenon capsule fibroblasts in tissue culture. Curr Eye Res 6:719-723, 1987.
`
`Skuta GL, Parrish RK II, Hodapp EA, Forster RK, Rockwood EJ: Zonular dialysis during
`extracapsular cataract extraction in pseudoexfoliation syndrome. Arch Ophthalmol 105:632-634,
`1987.
`
`Parel J-M, Parrish RK II, Nose I: An intraoperative intraocular pressure (IOP) monitor. Ophthalmic
`Surg 18:371-374, 1987.
`
`Fantes FE, Parrish RK II, Heuer DK, Sossi G: Subconjunctival 5-fluorouracil mechanisms of
`ocular penetration. Ophthalmic Surg 18:375-378, 1987.
`
`Skuta GL, Assil K, Parrish RK II, Folberg R, Weinreb RN: Filtering surgery in owl monkeys
`treated with the antimetabolite 5-fluorouracil 5'-monophosphate entrapped in multivesicular
`liposomes. Am J Ophthalmol 103:714-716, 1987.
`
`
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`8
`
`
`Loertscher HP, Mandelbaum S, Parel J-M, Parrish RK II: Noncontact trephination of the cornea
`using a pulsed hydrogen fluoride laser. Am J Ophthalmol 104:471-475, 1987.
`
`The Fluorouracil Filtering Surgery Study Group: Fluorouracil filtering surgery study one-year
`follow-up. Am J Ophthalmol 108:625-635, 1989.
`
`Buus DR, Tse DT, Parrish RK II: Spontaneous carotid cavernous fistula presenting with acute angle
`closure glaucoma. Arch Ophthalmol 197:596-597,1989.
`
`Darnley-Fisch, Byrne SF, Hughes JR, Parrish RK II, Feuer WJ: Contact B-scan echography in the
`assessment of optic nerve cupping. Am J Ophthalmol 109:55-61,1990.
`
`Albert DW, Wade EC, Parrish RK II, Flynn HW Jr, Slomovic AR, Tanenbaum M, Blodi C: A
`prospective study of angiographic cystoid macular edema one year after Nd: YAG posterior
`capsulotomy. Ann Ophthalmol 22:139-143,1990.
`
`Wright MM, Grajewski AL, Cristol SM, Parrish RK II: 5-fluorouracil after trabeculectomy and
`iridocorneal endothelial syndrome. Ophthalmology 98:314-316,1991.
`
`Munoz M, Parrish RK II: Hypertropia after implantation of a Molteno drainage device. Am J
`Ophthalmol 113:98-100,1992.
`
`The Fluorouracil Filtering Surgery Study Group: Risk factors for suprachoroidal hemorrhage after
`filtering surgery. Am J Ophthalmol 113:501-507,1992.
`
`Munoz M, Parrish RK II: Strabismus following implantation of Baerveldt drainage devices. Arch
`Ophthalmol 111:1096-1099,1993.
`
`The Fluorouracil Filtering Surgery Study Group: Three-year follow-up of the Fluorouracil Filtering
`Surgery Study. Am J Ophthalmol 115:82-92,1993.
`
`Parrish RK II: A perspective on the use of intraoperative mitomycin and postoperative 5-
`fluorouracil in the surgical management of glaucoma. Ophthalmic Pract 12: 62-68,1994.
`
`Foster RE, Smiddy WS, Alfonso EC, Parrish RK II: Secondary glaucoma associated with retained
`perfluorophenanthrene. Am J Ophthalmol 118: 253-255,1994.
`
`Munoz M, Parrish RK II, Murray TG: Open-angle glaucoma after pars plicata lensectomy and
`vitrectomy for congenital cataracts. Am J Ophthalmol 119:103-104,1995.
`
`Cohen SM, Flynn HW Jr, Palmberg PF, Gass JD, Grajewski AL, Parrish RK II: Treatment of
`hypotony maculopathy after trabeculectomy. Ophthalmic Surg Lasers 26:435-441,1995.
`
`Tsai JC, Feuer WJ, Parrish RK II, Grajewski AL: 5-Fluorouracil filtering surgery and neovascular
`glaucoma. Long-term follow-up of the original pilot study. Ophthalmology 102:887-892,
`discussion 892-893, 1995.
`
`The Fluorouracil Filtering Surgery Study Group: Five-year follow-up of the Fluorouracil Filtering
`Surgery Study. Am J Ophthalmol 121:349-366,1996.
`
`
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Hostyn P, Villain F, Malek-Chehire N, Kuhne F, Takesue Y, Parrish RK II, Parel JM: Implant
`biodegradable a liberation controlee de 5-FU dans la chirurgie du glaucoma. Etude experimentale. J
`Fr Ophtalmol 19:133-139,1996.
`
`9
`
`WuDunn D, Parrish RK II, Inana G: Gene heterogeneity in Hispanic families with autosomal
`dominant juvenile glaucoma. Ophthalmic Genet 17:87-94,1996.
`
`Parrish RK II: Visual impairment, visual functioning and quality of life assessments in patients with
`glaucoma: Trans Am Ophthalmol Soc. 94:919-1028,1996.
`
`Greenfield DS, Parrish RK II: Bleb rupture following filtering surgery with Mitomycin-C:
`Clinicopathologic correlations. Ophthalmic Surg Lasers 27:876-877,1996.
`
`Scott IU, Greenfield DS, Parrish RK II: Airbag-associated injury producing cyclodialysis cleft and
`ocular hypotony. Ophthalmic Surg Lasers 27:955-957,1996.
`
`Chen PP, Yamamoto T, Sawada A, Parrish RK II, Kitazawa Y: Use of antifibrosis agents and
`glaucoma drainage devices in the American and Japanese Glaucoma Societies. J Glaucoma 6:192-
`96,1997.
`
`Kangas TA, Greenfield DS, Flynn HW Jr, Parrish RK II, Palmberg P: Delayed-onset
`endophthalmitis associated with conjunctival filtering bleb. Ophthalmic Surg Lasers 28:746-752,
`1997.
`
`Chen PP, Gedde SJ, Budenz DL, Parrish RK II: Outpatient treatment of bleb infection.
`Arch Ophthalmol 115: 1124-1128,1997.
`
`
`
`Parrish RK II, Gedde SJ, Scott IU, Feuer WJ, Schiffman JC, et al. Visual function and quality of
`life among patients with glaucoma. Arch Ophthalmol 115:1447-1455,1997.
`
`Chen PP, Weaver YK, Budenz DL, Feuer WJ, Parrish RK II: Trabeculectomy function after
`cataract extraction. Ophthalmology 105:1928-1935,1998.
`
`Greenfield DS, Siatkowski RM, Glaser JS, Schatz NJ, Parrish RK II: The cupped disc; who needs
`neuroimaging? Ophthalmology 105:1866-1874,1998.
`
`Tsai JC, Grajewski AL, Parrish RK II: Surgical revision of glaucoma shunt implants. Ophthalmic
`Surg Lasers 30:41-46,1999.
`
`Greenfield DS, Parrish RK II: Detection of glaucomatous optic disk progression. Compr
`Ophthalmol Update 1: 87-96,2000.
`
`Lim MC, Doe EA, Vroman DT, Rosa RH Jr, Parrish RK II: Late onset lens particle glaucoma as a
`consequence of spontaneous dislocation of an intraocular lens in pseudoexfoliation syndrome. Am
`J Ophthalmol 132: 261-263,2001.
`
`Rhee DJ, Goldberg MJ, Parrish RK: Bilateral angle-closure glaucoma and ciliary body swelling
`from topiramate. Arch Ophthalmol 119:1721-1722,2001.
`
`
`
`
`

`

`
`
`
`
`
`
`
`10
`
`
`Parrish RK II, Schiffman JC, Feuer WJ, Heuer DK: Prognosis and risk factors for early
`postoperative wound leaks after trabeculectomy with and without 5-fluorouracil; The Fluorouracil
`Filtering Surgery Study Group. Am J Ophthalmol 132: 633-640, 2001.
`
`Feuer WJ, Parrish RK II, Schiffman JC, Anderson DR, Budenz DL, Wells M-C, Hess DJ, Kass
`MA, Gordon MO, and the Ocular Hypertension Treatment Study Group: The Ocular Hypertension
`Treatment Study: Reproducibility of cup/disk ratio measurements over time at an optic disc
`reading center. Am J Ophthalmol 133: 19-28,2002.
`
`Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK II, Wilson
`MR, Gordon MO: The Ocular Hypertension Treatment Study. A Randomized Trial Determines
`That Topical Ocular Hypotensive Medication Delays or Prevents the Onset of Primary Open-Angle
`Glaucoma. Arch Ophthalmol 120:701-713, 2002.
`
`Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller
`JP, Parrish RK II, Wilson MR, Kass MA. The Ocular Hypertension Treatment Study. Baseline
`Factors that Predict the Onset of Primary Open-Angle Glaucoma. Arch Ophthalmol 120:714-720,
`2002.
`
`Ceballos EM, Parrish RK II: Plain film imaging of Baerveldt glaucoma drainage implants. AJNR
`Am J Neuroradiol 6:935-937, 2002.
`
`Ceballos EM, Parrish RK II, Schiffman JC: Outcome of Baerveldt glaucoma drainage implants for
`the treatment of uveitic glaucoma. Ophthalmology 109:2256-2260, 2002
`
`Arroyave CP, Scott IU, Gedde SJ, Parrish RK II, Feuer WJ: Use of glaucoma drainage devices in
`the management of glaucoma associated with aniridia. Am J Ophthalmol 135:155-159,2003.
`
`Parrish RK, Palmberg P, Sheu W-P: A comparison of lantanoprost, bimatoprost, and travoprost in
`patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter
`study; the XLT Study Group. Am J Ophthalmol 135:688-703,2003.
`
`Escalona-Benz E, Benz MS, Briggs JW, Budenz DL, Parrish RK II, Murray TG: Uveal melanoma
`presenting as acute angle-closure glaucoma: Report of two cases. Am J Ophthalmol 136:756-758,
`2003.
`
`Parrish RK II: The case for glaucoma drainage implant surgery in patients with a poor prognosis for
`standard filtering procedure. Arch Ophthalmol 122: 104-105, 2004.
`
`Ventura LM, Porciatti V, Ishida K, Feuer WJ, Parrish RK 2nd: Pattern electroretinogram
`abnormality and glaucoma. Ophthalmology 112:10-9, 2005.
`
`Joshi AB, Parrish RK 2nd, Feuer WF: 2002 survey of the American Glaucoma Society: practice
`preferences for glaucoma surgery and antifibrotic use. J Glaucoma 14:172-4, 2005.
`
`Gedde SJ, Schiffman JC, Feuer WJ, Parrish RK 2nd, Heuer DK: The tube versus trabeculectomy
`study: design and baseline characteristics of study patients. Am J Ophthalmol 140:275-87, 2005.
`
`Parrish RK 2nd, Schiffman JC, Feuer WJ, Anderson DR, Budenz DL, Wells-Albornoz MC,
`Vandenbrouke R, Mass MA, Gordon MO: Ocular Hypertension Treatment Study Group: Test-
`
`
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`retest reproducibility of optic disk deterioration detected from stereophotographs by masked
`graders. Am J Ophthalmol 140:762-4, 2005.
`
`11
`
`Parrish RK 2nd . The European Glaucoma Prevention Study and the Ocular Hypertension
`Treatment Study: Why do two studies have different results? Curr Opin Ophthalmol 17:138-41,
`2006.
`Parrish RK II. Principles and Guidelines of a Curriculum for Ophthalmic Education of Medical
`Students. Klinische Monatsblatter fur Augenheilkunde. 203:S1-S19 2006.
`
`Keltner JL, Johnson CA, Anderson DR, Levine RA, Fan J, Cello KE, Quigley HA, Budenz DL,
`Parrish RK, Kass MA, Gordon MA; and the Ocular Hypertension Treatment Study Group. The
`association between glaucomatous visual fields and optic nerve head features in the Ocular
`Hypertension Treatment Study. Ophthalmology 113:1603-1612, 2006.
`Budenz DL, Anderson DR, Feuer WJ, Beiser JA, Schiffman J, Parrish RK 2nd, Piltz-Seymour JR,
`Gordon MO, Kass: Ocular Hypertension Treatment Study Group. Detection and prognostic
`significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study.
`Ophthalmology 113:2137-43, 2006.
`
`Tso MO, Goldberg MF, Lee AG, Selvarajah, Parrish RK 2nd, Zagorski Z. An international strategic
`plan to preserve and restore vision: four curricula of ophthalmic education. Am J Ophthalmol.
`143:859-65, 2007.
`Pham H, Mansberger S, Brandt JD, Damji K, Ramulu PY, Parrish RK. Argon laser trabeculoplasty
`versus selective laser trabeculoplasty. Surv Ophthalmol.53:641-646, 2008.
`Singh K, Lee BL, Wilson MR, Glaucoma Modified RAND-Like Methodology Group. A panel
`assessment of glaucoma management: modification of existing RAND-like methodology for
`consensus in ophthalmology. Part I: Methodology and design. Am J Ophthalmol 145:570-574
`2008.
`Singh K, Lee BL, Wilson MR, Glaucoma Modified RAND-Like Methodology Group. A panel
`assessment of glaucoma management: modification of existing RAND-like methodology for
`consensus in ophthalmology. Part I: Results and interpretation. Am J Ophthalmol 145:575-581,
`2008.
`Rauscher FM, Parrish RK 2nd. Atypical angle closures. Curr Opin Ophthalmol. 19:107-114, 2008.
`
`Parrish RK 2nd, Feuer WJ, Schiffman JC, Lichter PR, Musch DC; On Behalf Of The CIGTS Optic
`Disc Study Group. Five-year follow-up optic disc findings of the Collaborative Initial Glaucoma
`Treatment Study. Am J Ophthalmol. 147:717-724, 2009.
`
`Gedde SJ, Heuer DK, Parrish RK2nd . Tube Versus Trabeculectomy Study Group: Review of
`results from the Tube versus Trabeculectomy Study. Curr Opin Ophthalmol 21:123-128, 2010.
`
`Kass MA, Gordon MO, Gao F, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Miller JP,
`Parrish RK, Wilson MR; Ocular Hypertension Treatment Study Group. Delaying treatment of
`ocular hypertension: the Ocular Hypertension Treatment study. Arch Ophthalmol 128:276-87,
`2010.
`
`
`
`

`

`
`Cristol SM, Baumblatt JG, Icasiano E, Grajewski AL, Olivier MM, Parrish RK 2nd. Bilateral
`Acute Angle-Closure Associated With Systemic Lymphoma: A Report of 2 Cases. J Glaucoma
`20(2):115-117, 2011.
`
`12
`
`Masvidal D, Parrish RK 2nd , Lam BL.Structural-Functional Dissociation in Presumed
`Ethambutol Optic Neuropathy. J Neuroophthalmol. 30:305-320, 2010.
`
`
`
`
`
`
`
`19.
`
`OTHER WORKS, PUBLICATIONS AND ABSTRACTS
`
` A. Unrefereed Published Articles
`
`
`Parrish RK II, Davis H: Acetazolamide and compliance in the preoperative glaucoma patient.
`Chibret Int J Ophthalmol 4(2):16-19, 1987.
`
`Parrish RK II: Argon laser trabeculoplasty – clinical aspects, contraindications and complications.
`Buch Augenarzt 113: 166-171, 1988. (Laser der Ophthalmologie, edited by J Wolensak. Stuttgart:
`Enke)
`
`Potugal L, Parel JM, Parrish RK II, Bichon D: Intraocular evaluation of biodegradable polymers
`and controlled drug release. Proc Int Symposium Controlled Release Bioactive Materials 16: 105-
`106, 1989.
`
`Rader JE, Parrish RK II: Update on adjunctive antimetabolites in glaucoma surgery. Ophthalmol
`Clin North Am 4:861-888, 1991.
`
`Villain, F, Parel JM, Kiss K, Parrish RK II, Kuhne F, Takesue Y, Hostyn P: Laser sclerectomy and
`5-FU controlled drug release biodegradable implant for glaucoma. In: Proceedings of Ophthalmic
`Technologies III, edited by JM Parel, Q Ren. Bellingham: Washington: SPIE, 1993; pp. 240-244
`(Proc. SPIE 1877).
`
`Parrish RK II: The importance of fibrosis inhibition in high-risk glaucoma surgery. Curr Opin
`Ophthalmol 4(2):93-97, 1993.
`
`Parrish RK II: Antiproliferative surgery: Intraoperative mitomycin C versus postoperative 5-
`fluorouracil. Chibret Int J Ophthalmol 10:76-85, 1994.
`
`Parrish RK II: The future of ophthalmology residency training programs. Ophthalmic Surg 15:
`500-503, 1994.
`
`Parrish RK II: Patients are 1st priority for Bascom Palmer staff. Ophthalmology Times 21(25): 48-
`49, 1996.
`
`Grajewski AL, Rader J, Parrish RK II: The influence of cataract extraction on functioning filtering
`bleb. An Inst Barraquer (Barc). 25:745-747, 1996.
`
`Parrish RK II: Surgical modification of leaking filtering blebs. An Inst Barraquer (Barc) 27:203-
`206, 1998.
`
`
`
`
`
`
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`Parrish RK II: Comment on: Patient perceptions compared to objective findings in glaucoma.
`Evidence-Based Eye Care 1: 32-33, 1999
`
`13
`
`Rhee D, Parrish RK II: Comment on: Methodologic variations in estimating apparent progressive
`visual field loss in clinical trials of glaucoma treatment. Evidence-Based Eye Care 1: 84-85, 2000
`
`Parrish RK II: Comment on: Retinal nerve fiber layer thinner in glaucomatous and ocular
`hypertensive eyes. Evidence-Based Eye Care 1: 153, 2000.
`
`Parrish RK II: Comment on: The genetic aspects of adult-onset glaucoma: A perspective from the
`greater Toronto area. Evidence-Based Eye Care 1: 293, 2000.
`
`Parrish RK II: Glaucoma angle: Asking the right questions is key to improving care.
`Ophthalmology Times 25(18): 8, 2000.
`
`Parrish RK: Comment on: Vascular risk factors for primary open-angle glaucoma, by Marchine BL,
`et al. Evidence-Based Eye Care 2: 51, 2001.
`
`Parrish RK II: Comment on: Autologous conjunctival resurfacing of leaking filtering blebs, by
`Harris LD, Yang G, Feldman RM, et al. Evidence-Based Eye Care 2: 103, 2001.
`
`Parrish RK II: Comment on: Twenty-four hour time course of intraocular pressure in healthy and
`glaucomatous Africans: relation to sleep patterns, by Noel C, Abdoua M, Kabo AM, et al.
`Evidence-Based Eye Care 2: 154-155, 2001.
`
`Parrish RK II: Comment on: Survival analysis for success of Molteno tube implants. Evidence-
`Based Eye Care 3: 34-35, 2002.
`
`Parrish RK II: Comment on: Optic disc changes following trabeculectomy: longitudinal and
`localization of change. Evidence-Based Eye Care 3: 84-85, 2002.
`
`Parrish RK II: Comment on: Randomized controlled clinical trial of beta irradiation as an adjunct to
`trabeculectomy in open-angle glaucoma, by Rehman SU, et al. Evidence-Based Eye Care 3: 146-
`147, 2002.
`
`Parrish RK II: Comment on: Enzymatic sclerostomy pilot human study, by Dan JA, Honavar SG,
`Belyea DA, et al. Evidence-Based Eye Care 3: 201,2002.
`
`Parrish RK II, moderator: Ocular hypertension; what this means to you and your patients.
`Ophthalmology Times 27(Suppl 4), October 1, 2002.
`
`Parrish RK II, panelist: A closer look at OHTS [Ocular Hypertension Treatment Study]. Rev
`Ophthalmol 9 (Suppl to #10), October 2002.
`
`Parrish RK: The case for drainage implant surgery; the idea that filtering surgery produces lower
`IOPs is based on faulty data. Rev Ophthalmol 10: 95, 98, 2003.
`
`Parrish RK II: Comment on: Reduction of intraocular pressure and glaucoma progression, by Heijl
`A, Bengtsson B, Hyman L, et al. Evidence-Based Eye Care 4: 138-139, 2003.
`
`
`
`
`

`

`
`
`
`
`
`
`
`14
`Parrish RK II: Comment on: Viscocanalostomy versus trabeculectomy in white adults affected by
`open-angle glaucoma